Behrman Capital is a private equity firm focused on management buyouts, leveraged buildups and recapitalizations of established growth companies. Areas of interest include healthcare, defense, specialty manufacturing, business to business outsourcing, and information technology. Behrman looks to invest in the range from $25 to $125 million of equity capital in companies generating sales of $25 to $250 million. Behrman Capital was formed in 1991. The Firm is based in New York City with an additional office in San Francisco.
Join Mergr to view the latest updates and news from New York-based Behrman Capital.
Behrman Capital’s most common sectors for investment are healthcare services (18%) and life science (14%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (40%) and secondary buyout (31%). In total, Behrman Capital has invested in 17 US states. Its largest (disclosed) acquisition occurred in 2003 when it acquired ILC Industries for $303M.
In the last 3 years, Behrman Capital has exited 2 companies. The Firm’s most common exit type is trade sale (36%). Behrman Capital’s largest (disclosed) exit occurred in 2016 when it sold Data Device for $1.0B.
Join Mergr to view Behrman Capital’s full profile and discover more large private equity firms just like it.
No obligation. Cancel anytime.